Background: Unsuccessful treatment of Helicobacter pylori (HP) infection is constantly rising. Antibiotic susceptibility testing and selection of individualized therapy are expected to improve eradication of HP.
cation rates. Culture-guided personalized triple therapy is much more effective than standard triple therapy [1, 2, 3] as a first-line treatment of HP infection.
The aim of the current study is to assess the accuracy of microbiology testing for the diagnosis of HP infection and the effectiveness of culture-guided susceptibility tested antibiotic therapy in a group of Bulgarian patients with HP infection.
PATIENTS AND METHODS: Patients:
The study included 62HP-infected patients with dyspepsia, of them 34 female and 28male, with mean age -55±10 years. Of them 35 had unsuccessful eradication and 27 were treatment-naive.
Methods:
All patients had HP infection proven by 3 endoscopybased invasive methods including tissue sampling: rapid urease test, histology and PCR. Microbiology testing was performed in all cases. When HP colonies were isolated, strain susceptibility and resistance were determined by disc-diffusion method which evaluates areas with growth suppression. As a consequence of the proven antibiotic susceptibility a triple therapy in the naïve group and quadruple in the unsuccessfully treated group was applied. The effectiveness of susceptibility based eradication therapy was evaluated 2 months after initiation by stool antigen test and/or urea breath test.
Statistics: Fisher's exact test was used for assessment of the efficacy of the different treatment regimens. Evaluation of accuracy and precision of culture testing compared to other routine methods was performed, and sensitivity, specificity, positive predictive value (PPD) and negative predictive value (NPD) were calculated. Patients were considered HP positive if they had at least two positive tests for HP and this was accepted as "golden standard". Afterwards the result of each test was separately compared to the "golden standard".
RESULTS:
Baseline characteristics of the patients are shown in Fig.1 and Table 1 . All patients had chronic gastritis. The rate of positivity of the different methods for diagnosing the presence of HP infection is presented in Table 1 . HP colonies were isolated in 13 patients-21%, of them 9 naïve and 4 unsuccessfully eradicated.
The result from the culture test coincided completely with histology, the latter being accepted as "golden standard".
Culture vs Histology showed: Sensitivity -55 %, specificity -95.2%, PPV -84.6% and NPV -81.6%. Culture vs urea breath test showed: Sensitivity -100 %, specificity -100%, PPV -100% and NPV -100%.
Culture vs fecal antigen test showed: Sensitivity -31.8 %, specificity -100%, PPV -100% and NPV -50%.
It can be concluded that culture testing has a lower sensitivity compared to other tests which varies between 50% and 100%. The highest sensitivity -100% is observed when compared to urea breath test and high specificity between 95% -100% to the remaining methods. There is a full coincidence between culture and urea breath test.
It can be noted from 
Fig. 1. Endoscopic diagnosis of the patients with HP infections
Antibiotic susceptibility testing is performed in all 13 patients with isolated HP colonies and acquired strains.
In 9/13 of the cases -69.23%, of which 5 naïve and 4 treated, antibiotic resistance was found. In 5/13-38.5% the resistance was present to a single agent, in 4/13 -30.8% -to multiple agents. Clarithromycin-and metronidazole resistance were found in 38.4% of the cases for each antimicrobial agent. Ciprofloxacin resistance was proven in 30.7% -4/13 of the cases, amoxicillin resistance -in 1/13 -7.69%. The same value was present for Levofloxacin. In 8/13 -61.5% of the patients (5 from the naive and 3 from the treated) data for frequent antibiotic treatment in the past were present.
Resistance in the group of patients with previous unsuccessful eradication (treated)
The group included 3 women and 1 man with mean age -52.6 years. Those 4 patients have undergone 8 unsuccessful eradications, 7 of which included standard triple therapy and 1st line sequential eradication. All 4 patients were found resistant towards different antibiotic agents. Secondary resistance was found in three patients -75% of the cases towards Clarithromycin and Metronidazole. Ciprofloxacin resistance was proven in 50% of the cases and amoxicillin -in 25%. In two patients resistance towards three and four antibiotics was observed.
The cases with proven resistance and susceptibility testing are as follows:
In Patient No. 1 resistance towards three AB was proven: Clarithromycin, Metronidazole and Ciprofloxacin. Two courses of unsuccessful standard triple therapy were prescribed. Afterwards susceptibility towards amoxicillin, levofloxacin, tetracycline and rifabutin was found and the following quadruple eradication regimen was prescribed:
PPI ( In all patient HP infection was successfully eradicated. Follow-up was performed every six months, and one year after treatment no presence of HP was noted.
Resistance and susceptibility in treatment-naïve patients
The group includes 6 female and 3 male patients with mean age 57.8 years. Antibiotic resistance was present in 5of them -55.5% (4 female and 1 male).
Among treatment-naïve patients primary resistance towards clarithromycin was found in 2/9 of the cases -22.2%. The same percentage was present for ciprofloxacin and metronidazole. In one patient levofloxacin resistance was proven. In two patients combined resistance towards ciprofloxacin and metronidazole, and ciprofloxacin and levofloxacin, respectively, was discovered.
Susceptibility towards each antibiotic agent was tested and personalized treatment according to the results was prescribed.
All patients achieved successful eradication with susceptibility-guided therapy. In the remaining subjects no resistance was found and the prescribed susceptibility-guided triple therapy was successful. Table 3 summarizes the results of all hypotheses testing for the difference of the effectiveness of each therapeutic regimen. The effectiveness of the standard triple therapy significantly differs from the quadruple eradication regimen: bismuth-containing, 1st line sequential, sequential with probiotic, 2nd line sequential. Susceptibility-guided /triple and quadruple/ therapy is statistically significantly more effective than standard triple and any other empiric therapy.
The standard triple therapy as 1st line is effective in 23 cases -53.4 % PP and 42 % ITT(95% CI 28 -55 %), ineffective in 20cases -46.6%. Side effects were observed in 50% of the cases. The cost of treatment comes up to 137.80 lv.
Susceptibility-guided (triple or quadruple) therapy is effective in12 cases -100% PP and92% ITT. Side effects were encountered in 30.7%. The cost of treatment varies depending on the preferred antibiotic agent. The total expenses after adding the cost of susceptibility testing varies between 160 and 220 lv.
DISCUSSION:
Culture testing along with histology and urea breath test is considered one of the three most reliable tests for detecting infection with HP -the so called "golden standard" [4] . In terms of all parameters: sensitivity, specificity, positive predictive value, negative predictive value, accuracy, the cited values for culture treatment are 96%, 100%, 100%, 80%, 97%, respectively [5, 6] . Mangusoet al in 2011 [7] believe that culture has the highest accuracy -92.5% for diagnosis of HP infection compared to 4 other routine tests. According to our results histology and rapid urease test have the highest sensitivity -93.8%, followed by culture -75% and stool antigen test -62.5%.Regarding specificity the value for the three tests is 89%.In keeping with other authors` statements [8] we believe that the lower sensitivity rates of culture are probably due to density of HP bacteria and degree of colonization, as well as presence of gastric atrophy and intestinal metaplasia. These are some of the few inconveniences of the method in particular: capricious, exacting and labor-consuming, requiring professional qualification and competence. Attention should be paid to the preparatory measures before obtaining tissue samples and transport of the latter to the microbiology lab. According to our data culture testing has the accuracy and preciseness -91.9%, followed by histology and rapid urease test -90.3%. The lowest accuracy was found for the stool antigen test -58.1 % which is similar to other authors [5, 7, 9] . These results classify the method among those with high diagnostic yield, especially in cases with frequent recurrent HP infections, where it is able to provide reliable and accurate diagnosis. In cases where presence or absence of HP is debatable, its implementation as a verifying method is highly recommended.
The interest towards culture is mainly due to the possibility for antibiotic susceptibility testing and selection of proper personalized therapy. In recent years the effectiveness of the prescribed eradication regimen is unsatisfactory and unacceptably low. The reason for this is attributed to the high antibiotic resistance towards clarithromycin -the key antimicrobial agent. Nowadays, due to the high clarithromycin resistance in the last 15-20 years, the eradication rate following macrolide therapy has dropped dramatically below 75%.This is the main risk factor for the unsuccessful standard triple therapy including clarithromycin. There are enough data from randomized controlled studies [1, 2, 3, 10, 11] proving that culture followed by antibiotic susceptibility testing result in improvement of the eradication rate. One of the main tasks of the contemporary HP therapy is to minimize the rate of unsuccessful eradication. The analysis of our results underscores the fact that antibiotic resistance strongly correlates with eradication failure. In keeping with data from literature [1, 2, 11] our analysis shows that susceptibility-guided eradication therapy is the most successful one with 100% effectiveness when applied as triple or quadruple. Also, it shows optimal results in terms of compliance, side effects and cost. It should be preferred as initial therapy in cases with frequent antibiotic treatment or suspected antibiotic resistance. Therefore, in regions and populations with high antibiotic resistance (towards clarithromycin, quinolones and metronidazole) culture combined with antibiotic susceptibility testing is promising and should be performed before initial therapy. According to Boyanova et al. [12, 13] in the last 15 years clarithromycin resistance in Bulgaria has raised more than 2 times and is currently above 20%, which necessitates performing culture with antibiotic susceptibility testing in all cases with failed standard triple therapy. Compared to standard triple or any other empiric, susceptibility-guided therapy is not only more effective but also more profitable. Susceptibility-guided eradication is obligatory after two unsuccessful therapies, which is the official recommendation of Maastricht III and IV guidelines [10] . We support the idea that the perfect 100% effective 1st line therapy is antibiotic susceptibility-guided triple therapy and the perfect 2nd-and 3rd line therapy is antibiotic susceptibility-guided quadruple one.
After summarizing and thorough analyzing of our results we propose the following indications for microbiology testing: -All questionable cases in which the diagnosis of HP is ambiguous.
-All patients previously treated with macrolides or other antibiotics where resistance is suspected.
-All cases with one failed standard triple or other clarithromycin-containing therapy -All cases with persisting or recurrent HP infection -All cases where 'lege artis' diagnosis and treatment of Helicobacter pylori is pursued.
In conclusion: microbiology with antibiotic-susceptibility testing is a method which combines options for accurate diagnosis and optimal effective therapy of Helicobacter pylori infection. The indisputable advantage of this method is the guaranteed accurate diagnosis and successful individualized antibiotic therapy.
